incidence of pancreatitis with glp 1 GLP-1 receptor agonists and the risk acute pancreatitis: a living systematic review and meta-analysis Glucagon-Like Peptide-1 Receptor Agonists and

The Gupta 2026 systematic review found semaglutide hair loss was dose-dependent: doses below 2mg weekly were rarely implicated

Researchers are investigating the potential of these drugs further

They were working to move things forward despite the tragedy and were still making progress in the MDL

A landmark 2026 narrative review in Clinical Obesity (Urbina et al.) spanning 480,825 adults found vitamin D deficiency in 13.6% of users by 12 months, iron depletion with 2630% lower ferritin, and more than 60% consuming below requirements for calcium and iron (PubMed)

By mimicking the effects of the natural hormone GLP-1, these medications can help reduce appetite, improve insulin sensitivity, and promote weight loss

Clinical data shows all three sites deliver equivalent total drug exposure over the course of a week